Join Growin Stock Community!

麗豐-KY4137.TW Overview

TW StockBiotech. & Medical
(No presentation for 4137)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

麗豐-KY（4137）Overall Performance

麗豐-KY（4137）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

麗豐-KY（4137） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

麗豐-KY（4137）Key Information

麗豐-KY（4137）Profile

Chlitina Holding Limited, together with its subsidiaries, researches, develops, manufactures, and markets beauty skincare products in China and internationally. It offers makeup removers, facial cleansers, hydrating toners, lotions, moisturizing creams, facial masks, sunscreens, and foundation makeup products; eye care, anti-wrinkle, whitening, and hydrating products; and professional salon botanical extracts, herbal essence products, essential oils, and breast enlargement products under the Chlitina brand name. The company also provides enterprise management consulting services; medical cosmetology services; and cosmetology training services to beauty professionals, as well as operates as a dealer of health food and daily necessities products, skincare and supplementary health care products, and general practice and foods. The company sells its products online. As of December 31, 2019, it operated through a network of 4,809 CHLITINA franchised beauty salons in mainland China, Taiwan, Hong Kong, and South East Asia. Chlitina Holding Limited was founded in 1989 and is headquartered in Grand Cayman, the Cayman Islands.

麗豐-KY（4137）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
6.01
PE Ratio (TTM)
19.39
Forward PE
13.87
PS Ratio (TTM)
2.53
PB Ratio
1.99
Price-to-FCF
4.28
METRIC
VALUE
vs. INDUSTRY
Gross Margin
82.17%
Net Margin
13.03%
Revenue Growth (YoY)
-15.14%
Profit Growth (YoY)
-17.29%
3-Year Revenue Growth
10.28%
3-Year Profit Growth
11.83%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
6.01
PE Ratio (TTM)
19.39
Forward PE
13.87
PS Ratio (TTM)
2.53
PB Ratio
1.99
Price-to-FCF
4.28
Gross Margin
82.17%
Net Margin
13.03%
Revenue Growth (YoY)
-15.14%
Profit Growth (YoY)
-17.29%
3-Year Revenue Growth
10.28%
3-Year Profit Growth
11.83%
4137.TW logo

4137

麗豐-KY

116.50D

3.43%

(0.03)

  • When is 4137's latest earnings report released?

    The most recent financial report for 麗豐-KY (4137) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 4137's short-term business performance and financial health. For the latest updates on 4137's earnings releases, visit this page regularly.

  • Where does 4137 fall in the P/E River chart?

    According to historical valuation range analysis, 麗豐-KY (4137)'s current price-to-earnings (P/E) ratio is 11.48, placing it in the Value zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of 4137?

    According to the latest financial report, 麗豐-KY (4137) reported an Operating Profit of 263.03M with an Operating Margin of 25.66% this period, representing a growth of 46.71% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 4137's revenue growth?

    In the latest financial report, 麗豐-KY (4137) announced revenue of 1.03B, with a Year-Over-Year growth rate of 0.21%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 4137 have?

    At the end of the period, 麗豐-KY (4137) held Total Cash and Cash Equivalents of 3.64B, accounting for 0.4 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 4137 go with three margins increasing?

    In the latest report, 麗豐-KY (4137) achieved the “three margins increasing” benchmark, with a gross margin of 83.37%%, operating margin of 25.66%%, and net margin of 16.09%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 4137's profit trajectory and future growth potential.

  • Is 4137's EPS continuing to grow?

    According to the past four quarterly reports, 麗豐-KY (4137)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 2. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 4137?

    麗豐-KY (4137)'s Free Cash Flow (FCF) for the period is 926.91M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 184.95% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.